Stocky
INVA
Innoviva, Inc.
NASDAQ NMS - GLOBAL MARKET · Pharmaceuticals · US
20.51
▼ -1.68%

What's happening at Innoviva, Inc.

Innoviva, Inc.'s latest moves, explained simply — so you know why the numbers change.

Straight from SEC filings · updated 6 Aug 2026
Big update 5 Aug 2026

Q2 2026 financial results and balance sheet details

Quarterly earnings show how the company performed and what it owes versus owns.

SEC 10-Q · filed 2026-08-05 View filing ↗
Earnings 5 Aug 2026

Financial results announced August 5, 2026

Press release shares quarterly earnings news that affects stock price and investor decisions.

SEC 8-K · filed 2026-08-05 View filing ↗
People 18 May 2026

Derek Small and Mark DiPaolo resign from board May 12

Leadership changes can affect company strategy and how decisions get made going forward.

SEC 8-K · filed 2026-05-18 View filing ↗
Earnings 6 May 2026

Q1 2026 financial results and investment holdings

Quarterly earnings show company performance and what assets it owns or controls.

SEC 10-Q · filed 2026-05-06 View filing ↗
Earnings 6 May 2026

Financial results announced May 6, 2026

Press release shares quarterly earnings news investors use to decide if stock is worth buying.

SEC 8-K · filed 2026-05-06 View filing ↗
Governance 4 May 2026

Stockholders elect five board members May 4, 2026

Board elections determine who makes major company decisions and sets strategy.

SEC 8-K · filed 2026-05-04 View filing ↗
Earnings 25 Feb 2026

Financial results announced February 25, 2026

Press release shares earnings and business updates that impact investor confidence.

SEC 8-K · filed 2026-02-25 View filing ↗

Common questions

How does Stocky track Innoviva, Inc.'s company events?

Stocky reads Innoviva, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.

What was Innoviva, Inc.'s most recent SEC filing?

Innoviva, Inc.'s most recent tracked filing was a 10-Q on 5 Aug 2026: Q2 2026 financial results and balance sheet details.

Is this financial advice?

No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.

See Innoviva, Inc.'s full breakdown on Stocky →

Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.